RAM
MRKR icon

Riggs Asset Management’s Marker Therapeutics MRKR Stock Holding History

Riggs Asset Management’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,200
Closed -$1.84K – 569
2025
Q2 		$1.84K Hold
1,200
– – ﹤0.01% 668
2025
Q1 		$1.48K Hold
1,200
– – ﹤0.01% 428
2024
Q4 		$4.01K Hold
1,200
– – ﹤0.01% 312
2024
Q3 		$3.38K Sell
1,200
-200
-14% -$791 ﹤0.01% 323
2024
Q2 		$7.6K Hold
1,400
– – ﹤0.01% 272
2024
Q1 		$6.02K Sell
1,400
-200
-13% -$873 ﹤0.01% 272
2023
Q4 		$8.8K Sell
1,600
-750
-32% -$2.54K ﹤0.01% 254
2023
Q3 		$10.7K Sell
2,350
-200
-8% -$1.12K ﹤0.01% 236
2023
Q2 		$7.91K Hold
2,550
– – ﹤0.01% 259
2023
Q1 		$1.81K Buy
2,550
+700
+38% +$1.66K ﹤0.01% 303
2022
Q4 		$4.92K Hold
1,850
– – ﹤0.01% 240
2022
Q3 		$7K Buy
1,850
+200
+12% +$734 ﹤0.01% 236
2022
Q2 		$5K Hold
1,650
– – ﹤0.01% 240
2022
Q1 		$7K Hold
1,650
– – ﹤0.01% 245
2021
Q4 		$16K Sell
1,650
-1,300
-44% -$17.3K ﹤0.01% 220
2021
Q3 		$50K Hold
2,950
– – 0.02% 153
2021
Q2 		$82K Sell
2,950
-400
-12% -$10.5K 0.02% 135
2021
Q1 		$75K Hold
3,350
– – 0.02% 134
2020
Q4 		$49K Buy
+3,350
New +$52K 0.02% 131
2020
Q3 		– Sell
-3,750
Closed -$77K – 216
2020
Q2 		$77K Hold
3,750
– – 0.03% 84
2020
Q1 		$71K Sell
3,750
-15
-0.4% -$382 0.05% 83
2019
Q4 		$108K Sell
3,765
-837
-18% -$30.4K 0.04% 90
2019
Q3 		$235K Hold
4,602
– – 0.12% 50
2019
Q2 		$364K Buy
4,602
+10
+0.2% +$594 0.2% 46
2019
Q1 		$303K Buy
4,592
+1,865
+68% +$109K 0.21% 42
2018
Q4 		$151K Buy
2,727
+734
+37% +$53.5K 0.11% 59
2018
Q3 		$180K Buy
1,993
+120
+6% +$10.3K 0.09% 53
2018
Q2 		$177K Buy
+1,873
New +$95.5K 0.08% 59

Other funds holding MRKR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
TGIA
Torrey Growth & Income Advisors Del Mar, California $294M AUM 37.95% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Riggs Asset Management's MRKR Position: Q3 2025 in Review

Riggs Asset Management sold out of Marker Therapeutics (MRKR) in Q3 2025, closing a stake of 1,200 shares — an estimated $1.84K sold.

Riggs Asset Management first reported a position in MRKR in Q2 2018 and held it in 28 quarters. The position peaked at $364K in Q2 2019. 32 funds tracked by Wall St. Rank hold MRKR as of Q3 2025.

  • Riggs Asset Management reported no remaining Marker Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Riggs Asset Management sold 1,200 Marker Therapeutics shares in Q3 2025, an estimated $1.84K.
  • Riggs Asset Management first reported a position in Marker Therapeutics in Q2 2018 and held it in 28 quarters.
  • Riggs Asset Management's Marker Therapeutics position peaked at $364K in Q2 2019.
  • 32 funds tracked by Wall St. Rank held Marker Therapeutics as of Q3 2025.

Based on Riggs Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.